AK
Amit Kumar Singh
About Amit Kumar Singh
Data last updated:
Amit Kumar Singh is a Director at Jvin Pharma Private Limited (since 2019) and Director at Narcico Private Limited (since 2024). The companies operate in Business Services and Paper. The largest current company by reported revenue is Jvin Pharma Private Limited at ₹52.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Sep 2019 | 2019 | ₹52.8 Lakh (FY 2025) | Active | |
| Director | 02 Aug 2024 | 2024 | Active |
Board colleagues of Amit Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mamata Singh | 10639126 | Jvin Pharma Private Limited , Narcico Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Kumar Singh
Amit Kumar Singh currently holds 2 directorships: Jvin Pharma Private Limited (Director, since 20 Sep 2019, revenue ₹52.8 Lakh (FY 2025)); Narcico Private Limited (Director, since 02 Aug 2024).
Amit Kumar Singh was first appointed on 20 Sep 2019 as Director at Jvin Pharma Private Limited. The most recent appointment on record is 02 Aug 2024 at Narcico Private Limited.
The current boards of Amit Kumar Singh's companies include Mamata Singh (Jvin Pharma Private Limited).